MEG3 and neoplasm: Moreover, MEG3 (maternally expressed gene 3), which is expressed at a low level in ESCC, has been reported to inhibit the proliferation, migration, and apoptosis of ESCC cells in vitro and tumor development in vivo [46, 47].